代谢功能障碍相关的稳态性肝病:分子机制,临床影响和新兴治疗策略
Jeysson E Mejía-Guzmán1, Ramón A Belmont-Hernández1,2, Norberto C Chávez-Tapia1,3
1Translational Research Unit, Medica Sur Clinic & Foundation, Mexico City 14050, Mexico.
International journal of molecular sciences
|April 17, 2025
概括
与代谢功能障碍相关的脂肪性肝病 (MASLD) 是一个日益严重的公共卫生问题. 了解其分子驱动因素和探索新疗法对于更好的患者结果至关重要.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 代谢障碍 代谢障碍 代谢障碍
- 胃肠病学 胃肠病学
背景情况:
- 代谢功能障碍相关的脂肪性肝病 (MASLD),以前称为NAFLD,是一种普遍的疾病,与肥胖和糖尿病等代谢风险因素有关.
- 全球范围内,MASLD的患病率正在增加,这对公众健康构成了重大挑战.
- 这种疾病的范围从简单的肥胖症到肝硬化和肝细胞癌,导致大量的发病率和死亡率.
研究的目的:
- 审查 MASLD 病原体背后的分子机制.
- 讨论最近在了解MASLD中的遗传和表观遗传因素方面的进展.
- 为了突出MASLD的新治疗目标.
主要方法:
- 文献综述侧重于MASLD的分子机制.
- 对疾病进展中的遗传和表观遗传因素的分析.
- 识别和讨论新出现的治疗点.
主要成果:
- MASLD的发病包括脂质代谢失调,炎症,氧化应激,线粒体功能障碍和肠道微生物群的变化.
- 遗传和表观遗传因素在MASLD进展中发挥着作用.
- 潜在的治疗点包括PPAR,FGF和TRB激动剂.
结论:
- 综合早期诊断,分子理解,生活方式改变和个性化医疗的多学科方法对于管理MASLD至关重要.
- 迫切需要对创新的治疗方法和精准医学进行持续的研究,以阻止MASLD的进展并改善患者的治疗结果.
相关概念视频
Overview of Lipid Metabolism
828
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
828
Liver Physiology
381
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
381
Liver Regeneration
3.2K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
3.2K
Diseases of the Liver and Gallbladder
349
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
349
Chronic Pancreatitis II: Collaborative Care
49
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
49
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
465
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
465


